ZIGExN Co., Ltd. (TSE:3679) agreed to acquire 97.8% stake in VIVA VIDA MEDICAL LIFE CO.,LTD from an individual on August 7, 2019. Under the terms of the transaction, ZIGExN Co., Ltd. will acquire 880 shares. Upon completion, VIVA VIDA MEDICAL LIFE CO.,LTD will operate as subsidiary of ZIGExN Co., Ltd. For the year ended March 2019, VIVA VIDA MEDICAL LIFE CO.,LTD reported total assets of ¥86 million, net assets of ¥33 million, net sales of ¥161 million, and net income of ¥13 million. The agreement is expected to be signed on August 7, 2019. The transaction is subject to approval from relevant authorities. The transaction was resolved by the Board of ZIGExN Co., Ltd. on August 7, 2019. ZIGExN Co., Ltd. (TSE:3679) cancelled the acquisition of 97.8% stake in VIVA VIDA MEDICAL LIFE CO.,LTD from an individual on December 20, 2019. In light of various circumstances such as the management policies of the two companies and expected synergies, it was determined that it was reasonable to cancel the agreement, and the Board of Directors have decided to cancel the contract. The cancellation of this agreement will have no additional effect on the Group's consolidated business forecast.